|
CGEM Cullinan Therapeutics Inc 1789972 |
| Balance Sheet |
|
Current Assets
|
414,668,000 |
|
Assets
|
621,824,000 |
|
Current Liabilities
|
30,647,000 |
|
Liabilities
|
31,496,000 |
|
Equity
|
590,328,000 |
|
Shares Out
|
57,977,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-145,303,000 |
|
Investing Cash Flow
|
-136,314,000 |
| Market Analysis |
Market Cap
|
1,022,708,070 |
|
Price
|
8.51 |
|
BVPS
|
10.18 |
|
PB
|
0.84 |
|
EPS
|
-3.10 |
|
PS
|
0.49 |
|
FCF
|
-281,617,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CGEM documents filed with the SEC.
CGEM Filings
Clear
